Reducing and Removing Hyaluronic Acid Filler With Hyaluronidase
This trial is active, not recruiting.
|Start date||October 2012|
|End date||September 2017|
|Trial size||5 participants|
|Trial identifier||NCT01722916, STU68166|
The purpose of this study is to find how much hyaluronidase should be used when receiving injections of fillers.
|Endpoint classification||efficacy study|
|Intervention model||single group assignment|
|Primary purpose||basic science|
Dose of hyaluronidase injected until the filler is no longer detectable
time frame: 2 weeks
Male or female participants from 18 years up to 65 years old.
Inclusion Criteria: - Age 18 and over - The subjects are in good health - The subject has the willingness and the ability to understand and provide informed consent for the use of their tissue and communicate with the investigator Exclusion Criteria: - Under 18 years of age - Pregnancy or Lactation - Subjects who are unable to understand the protocol or to give informed consent - Subjects with mental illness - Recent Accutane use in the past 6 months - Subjects prone to hypertrophic and keloidal scarring - Subjects with tattoos and/or scars on upper medial arms (the treatment area) - Subjects with known hypersensitivity to hyaluronic acid
|Official title||Pilot Study of Appropriate Dosing for Reducing and Removing Hyaluronic Acid Filler With Hyaluronidase: A Randomized Control Clinical Trial|
|Principal investigator||Murad Alam, MD|
Call for more information